Carbon Dioxide Biomarker

Overview

Carbon dioxide (CO₂) testing in clinical practice typically measures either the total CO₂ (mainly bicarbonate, HCO₃⁻) in serum or plasma or the partial pressure of CO₂ (PaCO₂) in arterial blood. Total CO₂ reflects the bicarbonate level, which is a major component of the body’s acid base balance and is routinely included in basic and comprehensive metabolic panels. Arterial PaCO₂ directly indicates the adequacy of ventilation and is a key parameter in arterial blood gas (ABG) analysis used to assess respiratory function and acid base status. Abnormally high or low CO₂ values can indicate respiratory disorders, kidney disease, metabolic acidosis or alkalosis, and other conditions that disturb acid base homeostasis. Clinically, CO₂ measurements help diagnose and monitor lung disease, kidney disease, electrolyte and acid base disturbances, and guide acute and chronic treatment decisions.

Clinical Use Cases

Assessment of acid base balance as part of a basic or comprehensive metabolic panel (serum total CO₂ / bicarbonate).
Evaluation of electrolyte and metabolic disturbances, such as metabolic acidosis or metabolic alkalosis.
Monitoring and diagnosis of kidney disease, including chronic kidney disease and renal tubular disorders that affect bicarbonate handling.
Evaluation and management of lung and respiratory disorders (for example COPD, asthma exacerbations, respiratory failure) using PaCO₂ on arterial blood gases.
Monitoring of ventilation status in critically ill or mechanically ventilated patients via PaCO₂.
Assessment of response to treatment for conditions affecting breathing, acid base balance, or kidney function (for example oxygen therapy, ventilator adjustments, bicarbonate therapy).
Preoperative or emergency evaluation of patients with suspected respiratory or metabolic derangements using ABG analysis.

Specimen Types

Venous blood (serum or plasma) for total CO₂ / bicarbonate as part of metabolic or electrolyte panels.
Arterial blood for arterial blood gas analysis measuring PaCO₂.

Measurement Methods

Automated chemistry analyzers measuring total CO₂ (primarily bicarbonate) in serum or plasma as part of basic or comprehensive metabolic panels.
Arterial blood gas analyzers measuring pH, PaCO₂, and PaO₂ using potentiometric and related electrode-based methods.

Test Preparation and Influencing Factors

CO₂ (bicarbonate) testing is commonly performed on nonfasting samples, although fasting may be required if measured within a broader metabolic panel that includes glucose.
Medications such as diuretics, corticosteroids, laxatives, and bicarbonate-containing drugs can alter CO₂ levels by affecting fluid, electrolyte, or acid base balance.
Severe vomiting or diarrhea can significantly change bicarbonate and CO₂ levels by causing loss of gastric or intestinal fluids.
Respiratory rate and depth (hyperventilation or hypoventilation) directly influence PaCO₂ and thus ABG results.
Chronic lung diseases (for example COPD) and conditions causing hypoventilation can lead to chronically elevated PaCO₂ and secondary metabolic compensation.
High altitude can lower normal PaCO₂ due to ventilatory stimulation, so local reference values may differ.
Improper sample handling (delays in analysis, exposure of blood to air) may alter measured CO₂ and PaCO₂ values.